1 / 32

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer. Targeted Therapies Used in the Treatment of Patients With mCRC. Case 1: 70-year-old Man With Inoperable mCRC (cont). Ziv-aflibercept: Potential Side Effects. Ziv-aflibercept: Monitoring for Side Effects.

stone-livingston
Download Presentation

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer

  2. Targeted Therapies Used in the Treatment of Patients With mCRC

  3. Case 1: 70-year-old Man With Inoperable mCRC (cont)

  4. Ziv-aflibercept: Potential Side Effects

  5. Ziv-aflibercept: Monitoring for Side Effects

  6. Case 2: 47-year-old Woman With Disease Recurrence Following an Initial Diagnosis of Stage IIIC Colon Cancer

  7. Regorafenib: Key Patient Education Issues

  8. Regorafinib: Potential Side Effects

  9. Case 2: 47-year-old Woman With mCRC Receiving Regorafenib

  10. Regorafinib: Monitoring for Side Effects

  11. Hand-Foot Skin Reaction

  12. Strategies for Combating Fatigue

  13. The Importance of Patient Education

  14. Strategies for Prevention and Treatment of HFSR

  15. Hand-Foot Skin Reaction (cont)

  16. Hand-Foot Syndrome vs Hand-Foot Skin Reaction

  17. Summary: Strategies for Optimizing Use of New Targeted Agents in mCRC

  18. Abbreviations

  19. References

  20. References (cont)

  21. References (cont)

More Related